Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angina II: Classification01:27

Angina II: Classification

21
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
21
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

17
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
17

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal atlas of human atherosclerosis links granular vascular cell states to coronary artery disease risk.

medRxiv : the preprint server for health sciences·2026
Same author

Coronary CT-Based Differentiation of Pathologically Verified Fibroatheroma From Pathologic Intimal Thickening: Implications for Imaging of Advanced Lesions.

JACC. Cardiovascular imaging·2026
Same author

Pathological Analysis of Lipoprotein(a) Risk Variants and Culprit Coronary Thrombotic Lesions.

JAMA cardiology·2026
Same author

Pathophysiology of Coronary Restenosis.

Interventional cardiology clinics·2026
Same author

The silent culprit: why 'hidden' plaque ruptures matter.

European heart journal·2026
Same author

The Silent Barrier: Fibrous Tissue Ingrowth and Impaired Coronary Access Post-TAVR.

JACC. Cardiovascular interventions·2026

Related Experiment Video

Updated: Aug 25, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

25.6K

In-Stent Restenosis.

Kenji Kawai1, Renu Virmani1, Aloke V Finn2

  • 1CVPath Institute, 19 Firstfield Road, Gaithersburg, MD 20878, USA.

Interventional Cardiology Clinics
|October 15, 2022
PubMed
Summary
This summary is machine-generated.

In-stent restenosis (ISR) is a complication after coronary intervention, even with drug-eluting stents. Neoatherosclerosis accelerates ISR, and treatment choices depend on patient factors and lesion characteristics.

Keywords:
Bare-metal stentDrug-coated balloonDrug-eluting stentIntravascular imagingNeoatherosclerosis

More Related Videos

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
09:46

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

13.9K
Monitoring the Wall Mechanics During Stent Deployment in a Vessel
08:28

Monitoring the Wall Mechanics During Stent Deployment in a Vessel

Published on: May 8, 2012

9.3K

Related Experiment Videos

Last Updated: Aug 25, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

25.6K
Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
09:46

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

13.9K
Monitoring the Wall Mechanics During Stent Deployment in a Vessel
08:28

Monitoring the Wall Mechanics During Stent Deployment in a Vessel

Published on: May 8, 2012

9.3K

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • In-stent restenosis (ISR) is a significant complication following percutaneous coronary intervention (PCI), persisting despite advancements like drug-eluting stents.
  • Neoatherosclerosis, a key pathological feature of ISR, demonstrates accelerated progression in drug-eluting stents compared to bare-metal stents.
  • Current treatment strategies for ISR remain suboptimal, necessitating further research and improved therapeutic approaches.

Purpose of the Study:

  • To review the current understanding of in-stent restenosis (ISR) pathology, diagnosis, and treatment.
  • To highlight the role of neoatherosclerosis in ISR development and progression.
  • To discuss diagnostic modalities and therapeutic options for managing ISR.

Main Methods:

  • Review of current literature on in-stent restenosis, neoatherosclerosis, and interventional cardiology treatments.
  • Analysis of diagnostic techniques including coronary angiography and computed tomography angiography.
  • Evaluation of treatment strategies such as drug-coated balloons and stent reimplantation.

Main Results:

  • Neoatherosclerosis is a critical factor in ISR, particularly accelerated in drug-eluting stents.
  • Coronary angiography remains the gold standard for ISR morphology assessment, with computed tomography angiography as a promising noninvasive alternative.
  • Optimal treatment selection for ISR requires careful consideration of patient clinical background and lesion morphology.

Conclusions:

  • ISR remains a clinical challenge, with neoatherosclerosis being a major contributor.
  • Accurate diagnosis through angiography or CT angiography is crucial for guiding treatment decisions.
  • Personalized treatment strategies, including drug-coated balloons and stent reimplantation, are essential for managing ISR effectively.